Discovery20
Latest Headlines
Trending stories — sign in for a personalized feed
Today
From Funan to the World Stage, Homegrown mc.2 Acquired by Global Leader Hunter Douglas After Two Decades of Consumer-Led Innovation
a minute ago
BOE, UNESCO introduce Asia-Pacific Science Club Network & 2026 Science Challenge
a minute ago
Scorpio Tankers Inc. Prices Reopening of 1.75% Convertible Senior Notes due 2031 and Concurrent Stock Repurchase
34 minutes ago
Afya Limited Announces First-Quarter 2026 Financial Results
3 hours ago
InnoCare Announces Approval of a Phase II Clinical Trial of TYK2 Inhibitor ICP-488 for Sjögren's Syndrome in China
3 hours ago
V2X, INC. ANNOUNCES PRICING OF OFFERING OF APPROXIMATELY 2.0 MILLION SHARES OF COMMON STOCK IN SECONDARY OFFERING BY VERTEX AEROSPACE
3 hours ago
Genco Shipping & Trading Limited Issues Statement Regarding Diana’s Unsubstantiated Assertions
3 hours ago
MediPharm Labs Sets Date to Report First Quarter 2026 Financial Results
3 hours ago
MP Materials Reports First Quarter 2026 Results
4 hours ago
Greenfire Resources Reports Voting Results from 2026 Annual Meeting of Shareholders
4 hours ago
Gamehost to Hold Special Meeting on June 11, 2026 to Approve Sale Transaction to Pure Casino
4 hours ago
Yesterday
Goldman Sachs BDC, Inc. Reports March 31, 2026 Financial Results and Announces Second Quarterly 2026 Base Dividend of $0.32 Per Share.
4 hours ago
Cue Biopharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4 hours ago
Journey Energy Inc. Reports Its First Quarter 2026 Financial and Operating Results
4 hours ago
Vanda Pharmaceuticals Announces Participation at May 2026 Investor Conferences
5 hours ago
Badger Announces Pricing of C$300 Million Senior Unsecured Notes
5 hours ago
IREN Secures $3.4bn AI Cloud Contract with NVIDIA
5 hours ago
Perseus Mining Appoints Chief Operating Officer
5 hours ago
Maxim Power Corp. Announces 2026 First Quarter Financial and Operating Results
5 hours ago
Signet Jewelers Appoints Jeffrey Gennette to Its Board
5 hours ago
Published May 3 2021
3 min read
Press Release May 03 2021
Natco Pharma Limited has informed the Exchange regarding a press release dated May 03, 2021, titled "NATCO receives Emergency Use approval for Baricitinibtablets for Covid-19 treatment".